The pace of biopharmaceutical company announcements about COVID-19 concerns impacting clinical trials and other areas of their business is picking up. At least seven companies made such disclosures on 26 and 27 March, including Vertex Pharmaceuticals Inc.
Vertex said the supply chain for its cystic fibrosis medications is holding steady and it anticipates no problems getting drugs...






